CLINICAL_TRIALS
trial_result
· 2019-08-19
Clinical Trial Update: A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase [Phase 3]
Summary
Phase 3 trial update on imatinib and nilotinib in chronic myeloid leukemia in chronic phase; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2019-08-19